Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: A potential new contraceptive strategy

Marcelo C. Batista, Tannia P. Cartledge, Ann W. Zellmer, Maria J. Merino, Constantine Axiotis, D. Lynn Loriaux, Lynnette K. Nieman

Research output: Contribution to journalArticle

66 Scopus citations

Abstract

Objective: Our objective was to determine if a progesterone antagonist might interdict the development of a secretory endometrium. Study Design: Eleven normally cycling women not at risk for pregnancy received RU 486 (1 mg/day orally) or placebo throughout one menstrual cycle in a randomized, double-blind, crossover fashion. Estradiol, progesterone, and placental protein 14 were measured every 3 days; luteinizing hormone was measured until the midcycle surge was detected. An endometrial biopsy was performed on luteal phase day 7 to 9 and interpreted with Noyes' criteria. Differences between treatment groups were analyzed by the Student t test. Results: RU 486 delayed ovulation, retarded endometrial maturation, and reduced peak levels of placental protein 14 without affecting gonadal steroid production. The abnormalities in endometrial morphology and function are similar to those seen in infertile women with luteal phase defects. Conclusion: We hypothesize that this regimen of antiprogestin administration may prevent implantation and offer a novel strategy for fertility control.

Original languageEnglish (US)
Pages (from-to)60-65
Number of pages6
JournalAmerican journal of obstetrics and gynecology
Volume167
Issue number1
DOIs
StatePublished - Jan 1 1992

Keywords

  • RU 486
  • antiprogestins
  • contraception
  • endometrium

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: A potential new contraceptive strategy'. Together they form a unique fingerprint.

  • Cite this